Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: results from parallel-group comparison trials.
about
The management of glaucoma and intraocular hypertension: current approaches and recent advancesComparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: a patient-use studyWhat comparative effectiveness research is needed? A framework for using guidelines and systematic reviews to identify evidence gaps and research priorities.Effects of prostaglandin analogues on aqueous humor outflow pathways.Bimatoprost 0.01% in treatment-naïve patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical settingIntraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases.Effects of Latanoprost and Bimatoprost on the Expression of Molecules Relevant to Ocular Inflow and Outflow PathwaysTolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study.Ocular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes.Efficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre studyLatanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review.The use of prostaglandin analogs in the uveitic patient.Patient considerations in ocular hypertension: role of bimatoprost ophthalmic solution.Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataractA novel convergent synthesis of the antiglaucoma PGF2α analogue bimatoprost.Bimatoprost 0.01 % for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting.Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension.
P2860
Q22305849-E9B01BF4-0D73-465B-BD10-E1EE29BDF26AQ33343120-8B928E99-F1E4-4B22-830C-A47ADFF1F740Q34258967-FCAE5E51-7DD1-4B8E-BA51-524E23EA3B0AQ34393424-72A3EA56-C66B-4C84-B0A6-51B4EF843183Q34901153-E378232F-477E-4246-B691-FF6EC58EB820Q35762707-46A43316-2BD3-4CD4-B123-7DC7A2DAD791Q35949978-BF619A62-04CA-4E77-AEBB-A93D0C810069Q35969296-15973803-DD76-4F19-A076-FAE438BAF1DFQ36134942-AE4A7B23-F6F7-4840-9C27-F3E5147E8F2FQ37079208-DF4455E8-C4F1-43CC-AFAF-86E14ABA809AQ37475890-32D2D460-16AD-4453-8D8C-7BB417594B96Q37577392-A98DCCCF-2081-4757-BF28-A7DCD3907011Q37940590-F497D69C-3EB9-4623-A31D-94685F2FD71AQ39458214-4B675940-F8E5-4774-9B07-C451288D785AQ42240928-AF2C60D8-173F-48A6-BCAD-F440EB396733Q44637557-DD882174-0977-49B7-A7FB-20CD200DD265Q52995234-17A15F39-07C2-40A4-ADBC-22C72839DC8CQ53079997-246D8840-4381-4309-8C2E-A4733BDA9AAA
P2860
Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: results from parallel-group comparison trials.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Bimatoprost versus latanoprost ...... allel-group comparison trials.
@ast
Bimatoprost versus latanoprost ...... allel-group comparison trials.
@en
type
label
Bimatoprost versus latanoprost ...... allel-group comparison trials.
@ast
Bimatoprost versus latanoprost ...... allel-group comparison trials.
@en
prefLabel
Bimatoprost versus latanoprost ...... allel-group comparison trials.
@ast
Bimatoprost versus latanoprost ...... allel-group comparison trials.
@en
P2093
P2860
P356
P1433
P1476
Bimatoprost versus latanoprost ...... allel-group comparison trials.
@en
P2093
Monte S Dirks
Robert J Noecker
Steven T Simmons
P2860
P2888
P304
P356
10.1007/BF02850157
P407
P577
2004-07-01T00:00:00Z